- Home
- LVLU vs CVM Comparison
LVLU vs CVM Comparison
Compare LVLU & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVLU
- CVM
- Stock Information
- Founded
- LVLU 1996
- CVM 1983
- Country
- LVLU United States
- CVM United States
- Employees
- LVLU N/A
- CVM N/A
- Industry
- LVLU Catalog/Specialty Distribution
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LVLU Consumer Discretionary
- CVM Health Care
- Exchange
- LVLU Nasdaq
- CVM Nasdaq
- Market Cap
- LVLU 47.5M
- CVM 40.1M
- IPO Year
- LVLU 2021
- CVM 1987
- Fundamental
- Price
- LVLU $0.89
- CVM $0.41
- Analyst Decision
- LVLU Hold
- CVM
- Analyst Count
- LVLU 3
- CVM 0
- Target Price
- LVLU $1.58
- CVM N/A
- AVG Volume (30 Days)
- LVLU 36.4K
- CVM 1.5M
- Earning Date
- LVLU 03-05-2025
- CVM 01-13-2025
- Dividend Yield
- LVLU N/A
- CVM N/A
- EPS Growth
- LVLU N/A
- CVM N/A
- EPS
- LVLU N/A
- CVM N/A
- Revenue
- LVLU $324,699,000.00
- CVM N/A
- Revenue This Year
- LVLU N/A
- CVM N/A
- Revenue Next Year
- LVLU $1.72
- CVM N/A
- P/E Ratio
- LVLU N/A
- CVM N/A
- Revenue Growth
- LVLU N/A
- CVM N/A
- 52 Week Low
- LVLU $0.89
- CVM $0.36
- 52 Week High
- LVLU $2.13
- CVM $3.08
- Technical
- Relative Strength Index (RSI)
- LVLU 31.13
- CVM 39.22
- Support Level
- LVLU $0.92
- CVM $0.37
- Resistance Level
- LVLU $1.03
- CVM $0.42
- Average True Range (ATR)
- LVLU 0.08
- CVM 0.03
- MACD
- LVLU -0.01
- CVM 0.00
- Stochastic Oscillator
- LVLU 0.00
- CVM 58.37
About LVLU Lulu's Fashion Lounge Holdings Inc.
Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates majority of its revenue from customers based in the United States.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.